REM sleep deprivation promotes a dopaminergic influence in the striatal MT2 anxiolytic-like effects

Publication date: Available online 10 November 2015 Source:Sleep Science Author(s): Ana Carolina D. Noseda, Adriano D.S. Targa, Lais S. Rodrigues, Mariana F. Aurich, Marcelo M.S. Lima The aim of this study was to investigate the possible anxiolytic-like effects of striatal MT2 activation, and its counteraction induced by the selective blockade of this receptor. Furthermore, we analyzed this condition under the paradigm of rapid eye movement (REM) sleep deprivation (REMSD) and the animal model of Parkinson’s disease (PD) induced by rotenone. Male Wistar rats were infused with intranigral rotenone (12μg/μL), and seven days were subjected to 24h of REMSD. Afterwards the rats underwent striatal micro-infusions of selective melatonin MT2 receptor agonist, 8-M-PDOT (10μg/μL) or selective melatonin MT2 receptor antagonist, 4-P-PDOT (5μg/μL) or vehicle. Subsequently, the animals were tested in the open-field (OP) and elevated plus maze (EPM) tests. Results indicated that the activation of MT2 receptors produced anxiolytic-like effects. In opposite, the MT2 blockade did not show an anxiogenic-like effect. Besides, REMSD induced anxiolytic-like effects similar to 8-M-PDOT. MT2 activation generated a prevalent locomotor increase compared to MT2 blockade in the context of REMSD. Together, these results suggest a striatal MT2 modulation associated to the REMSD-induced dopaminergic supersensitivity causing a possible dopaminergic influence in the MT2 anxiolytic-like e...
Source: Sleep Science - Category: Sleep Medicine Source Type: research